참고문헌
- Aruna VK, David F (2011). Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol, 51, 311-36 https://doi.org/10.1146/annurev-pharmtox-010510-100611
- Bentires-Alj M, Barbu V, Fillet M, et al (2003). NF-kappaB transcription factor induces drug resistance through MDR1expression in cancer cells. Oncogene, 22, 90-7. https://doi.org/10.1038/sj.onc.1206056
- Breier A, Barancík M, Sulová Z, et al (2005). P-glycoprotein implications of metabolism of neoplastic cells and cancer therapy. Curr Cancer Drug Targets, 5, 457-68. https://doi.org/10.2174/1568009054863636
- Eichele K, Ramer R, Hinz B (2008). Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemothempeuties-induced apoptosis of human cervical carcinoma cells. Oncogene, 27, 3032-44. https://doi.org/10.1038/sj.onc.1210962
-
Hyung GK, Tran TH, Eun HH (2011). Metformin inhibits P-glycoprotein expression via the NF-
$\kappa B$ pathway and CRE transcriptional activity through AMPK activation. Br J Pharmacol, 162, 1096-108 https://doi.org/10.1111/j.1476-5381.2010.01101.x - Humberto G, Alun MD (2011). Regulation of neural process growth, elaboration and structural plasticity by NF-ΚB. Cell, 34, 316-26.
- Liu B, Qu L, Tao H (2009). Cyclo-oxygenase 2 up-regulates the effect of multidrug resistance. Cell Biol int, 34, 21-5.
-
Liu Guohong, Wang Surong, Wang Bo (2006). Impact of NF-
$\kappa B$ on P-glycoprotein-mediated multidrug resistance in ovarian cancer cells. Basic Clin Med, 16, 187-91. - Miller B, Patel VA, Sorokin A (2006). Cyclooxygenase-2 rescues rat mesangial cells from apoptosis induced by adriamycin via upregulation of multidrug resistance protein 1 (P-glycoprotein). J Am Soc Nephrol, 17, 977-85. https://doi.org/10.1681/ASN.2005101076
- Nardone G, Rocco A, Vaira D, et al (2004). Espression of Cox-2, mPGE-synthasel, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of Hpylori-related gastric carcineyenesis. J Pathol, 202, 305-12. https://doi.org/10.1002/path.1512
-
Yang TT, Xue TY, Xu W (2010). NF-
$\kappa B$ inhibitor PDTC reversed K562/$AO_{2}$ cell resistance and its mechanism. Experimental Hematology, 8, 903-8. - Yu L, Wu WK, Li ZJ, et al (2009). Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity. Mol Pharmacol, 75, 1364-73. https://doi.org/10.1124/mol.108.053546
- Zatelli MC, MolèD, Tagliati F, et al (2009). Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB. Cell Oncol, 31, 457-65.
- Zhang MX, Zhang LJ, Gu KS (2009). Paclitaxel and celecoxib on the expression of cyclooxygenase-2 and P-glycoprotein in human gastric adenocarcinoma cell line BGC823. Clin Oncol, 14, 602-5.
피인용 문헌
- The -765G>C Polymorphism in the Cyclooxygenase-2 Gene and Digestive System Cancer: a Meta-analysis vol.15, pp.19, 2014, https://doi.org/10.7314/APJCP.2014.15.19.8301
- The 765G>C Polymorphism in the Cyclooxygenase-2 Gene and Gastric Cancer Risk: an Update by Meta-analysis vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2863